108 related articles for article (PubMed ID: 17080180)
1. Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.
Andre F; Pusztai L
Nat Clin Pract Oncol; 2006 Nov; 3(11):621-32. PubMed ID: 17080180
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer.
Güler EN
Eur J Breast Health; 2017 Oct; 13(4):168-174. PubMed ID: 29082373
[TBL] [Abstract][Full Text] [Related]
3. Genetic diagnosis of familial breast cancer using clonal sequencing.
Morgan JE; Carr IM; Sheridan E; Chu CE; Hayward B; Camm N; Lindsay HA; Mattocks CJ; Markham AF; Bonthron DT; Taylor GR
Hum Mutat; 2010 Apr; 31(4):484-91. PubMed ID: 20127978
[TBL] [Abstract][Full Text] [Related]
4. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in lab-on-a-chip systems for breast cancer metastasis research.
Firatligil-Yildirir B; Yalcin-Ozuysal O; Nonappa
Nanoscale Adv; 2023 May; 5(9):2375-2393. PubMed ID: 37143816
[TBL] [Abstract][Full Text] [Related]
6. JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer.
Cioni B; Ratti S; Piva A; Tripodi I; Milani M; Menichetti F; Langella T; Botti L; De Cecco L; Chiodoni C; Lecis D; Colombo MP
Mol Cancer Res; 2023 Jun; 21(6):614-627. PubMed ID: 36867680
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
Mirza S; Bhadresha K; Mughal MJ; McCabe M; Shahbazi R; Ruff P; Penny C
Front Oncol; 2022; 12():1023565. PubMed ID: 36686736
[TBL] [Abstract][Full Text] [Related]
8. Breast Carcinoma Receptor Expression in a Caribbean Population.
Ramdass MJ; Gonzales J; Maharaj D; Simeon D; Barrow S
Surg J (N Y); 2022 Jul; 8(3):e262-e265. PubMed ID: 36131945
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in nanomaterials-based electrochemical immunosensors and aptasensors for HER2 assessment in breast cancer.
Ahirwar R
Mikrochim Acta; 2021 Sep; 188(10):317. PubMed ID: 34476602
[TBL] [Abstract][Full Text] [Related]
10. Molecular Biology in the Breast Clinics-Current status and future perspectives.
Parmar V; Nair NS; Thakkar P; Chitkara G
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):7-20. PubMed ID: 33994723
[TBL] [Abstract][Full Text] [Related]
11. A tumor microenvironment-specific gene expression signature predicts chemotherapy resistance in colorectal cancer patients.
Zhu X; Tian X; Ji L; Zhang X; Cao Y; Shen C; Hu Y; Wong JWH; Fang JY; Hong J; Chen H
NPJ Precis Oncol; 2021 Feb; 5(1):7. PubMed ID: 33580207
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
13. Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters.
Sudhakaran M; Parra MR; Stoub H; Gallo KA; Doseff AI
Biochem Pharmacol; 2020 Dec; 182():114259. PubMed ID: 33011162
[TBL] [Abstract][Full Text] [Related]
14. Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Trimboli RM; Giorgi Rossi P; Battisti NML; Cozzi A; Magni V; Zanardo M; Sardanelli F
Insights Imaging; 2020 Sep; 11(1):105. PubMed ID: 32975658
[TBL] [Abstract][Full Text] [Related]
15. Molecular classification of breast cancer: A retrospective cohort study.
Al-Thoubaity FK
Ann Med Surg (Lond); 2020 Jan; 49():44-48. PubMed ID: 31890196
[TBL] [Abstract][Full Text] [Related]
16. Pathways to Endocrine Therapy Resistance in Breast Cancer.
Haque MM; Desai KV
Front Endocrinol (Lausanne); 2019; 10():573. PubMed ID: 31496995
[TBL] [Abstract][Full Text] [Related]
17. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.
Hamdan FH; Johnsen SA
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12343-E12352. PubMed ID: 30541891
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis.
Walaszek K; Lower EE; Ziolkowski P; Weber GF
Br J Cancer; 2018 Nov; 119(10):1259-1266. PubMed ID: 30353046
[TBL] [Abstract][Full Text] [Related]
19. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
[TBL] [Abstract][Full Text] [Related]
20. Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.
Noman AS; Uddin M; Chowdhury AA; Nayeem MJ; Raihan Z; Rashid MI; Azad AK; Rahman ML; Barua D; Sultana A; Shirin A; Ferdous J; Parag RR; Rahman SM; Mahmud MR; Jerin CS; Jahan N; Siddiqua A; Ara T; Sabur EB; Alam SS; Baidya S; Akther S; Rahman MZ; Banu T; Murugan AK; Sabri S; Islam SMS; Karakas B; Aboussekhra A; Yeger H; Farhat WA; Islam SS
Sci Rep; 2017 May; 7(1):1796. PubMed ID: 28496132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
